Building Your Care Team & First Visit Prep
At a Glance
A20 haploinsufficiency is best managed by a coordinated team, usually led by a rheumatologist or immunologist, with genetics, digestive, and eye specialists added as needed. Bring the genetic report, symptom timeline, family history, and prior test records to the first visit.
Managing A20 Haploinsufficiency (HA20) requires more than just a single doctor; it requires a coordinated team of specialists who understand how this rare genetic condition affects different parts of the body. Because HA20 can involve the immune system, the gut, the joints, and the eyes, you or your child will likely need a “multidisciplinary” team to provide comprehensive care [1][2].
Your Core Care Team
A central group of specialists typically forms the foundation of care. It is helpful to designate one specialist—usually the rheumatologist or immunologist—as the “captain” who coordinates all other referrals [3].
- Rheumatologist: Often the primary specialist for HA20, they manage the “autoinflammatory” aspects of the disease, including fevers, joint pain, and biologics [4].
- Clinical Immunologist: These experts focus on how the immune system is functioning overall. While recurrent infections are reported in some HA20 cohorts, not every patient has a primary immunodeficiency [5]. Infections can also result from immunosuppressive treatments or other specific immune factors, so an immunologist helps distinguish the cause.
- Medical Geneticist & Genetic Counselor: They interpret the TNFAIP3 variant and explain what the results mean for the rest of the family [1][2].
- Gastroenterologist: Essential if you or your child has abdominal pain, diarrhea, or mouth/intestinal ulcers. They may perform endoscopies to look for inflammation in the gut [5][6].
- Ophthalmologist: Baseline and follow-up eye assessments should be individualized by age, symptoms, prior eye disease, genotype, and specialist advice [7][5]. Urgent assessment is required for eye pain, redness, photophobia, or vision changes.
The Role of Genetic Counseling
Because HA20 is an autosomal dominant condition, genetic counseling is a critical part of the process for the whole family [1].
- Inheritance Patterns: A parent who carries the variant has a 50% chance of passing it to each child [8]. However, in some cases, the variant is de novo, meaning it started with the patient and neither parent is a carrier [9].
- Cascade Testing: Counselors help determine which relatives should be tested—a process called “cascade evaluation” [1].
- Variable Severity: It is important to remember that having the same genetic variant does not mean everyone will have the same symptoms. One relative might be severely affected while another has almost no symptoms [10].
Preparing for Your First Specialist Visit
Rare disease specialists often have limited time, so arriving prepared ensures you get the most out of the appointment. Bring a physical or digital folder containing:
- The Full Genetic Report: This must include the exact variant (the “c.” and “p.” notations) and the laboratory’s classification [1].
- Symptom Timeline: A dated list of symptoms. Note the age at the first symptom, how long fevers typically last, and which symptoms happen together during a flare [6][10].
- The “Photo Album”: Clear photographs of rashes, mouth ulcers, or swollen joints. These visual clues are invaluable for doctors because flares may not be active during the office visit [10].
- Family Medical History: A record of any relatives with similar issues, even if they were diagnosed with other conditions like Behçet’s, Crohn’s disease, or Lupus [11][12].
- Lab and Procedure Records: Copies of prior blood tests (especially inflammatory markers like CRP), imaging (X-rays/MRIs), and any past biopsy or endoscopy reports [13][10].
Consider preparing practical tools such as a school or work medication letter, an updated medication list, an emergency-contact card, and a written sick-day and fever plan.
Evaluating a Potential Specialist
When meeting a new doctor, you are also evaluating if they are the right fit for managing a rare diagnosis. You might consider asking:
- “How many other patients with HA20 or similar monogenic autoinflammatory diseases do you currently treat?” [6]
- “How do you coordinate care when we need to see multiple specialists?” [3]
- “Are you comfortable managing biologics and monitoring for anti-drug antibodies?” [13]
- “Do you have a structured plan for long-term monitoring of disease activity and organ health?” [14]
If a specialist seems unfamiliar with HA20, don’t be afraid to ask for a referral to a regional or national center of excellence that specializes in autoinflammatory disorders [3][15].
Common questions in this guide
What specialists are usually involved in HA20 care?
What should I bring to my first A20 haploinsufficiency appointment?
How does genetic counseling help families affected by HA20?
How can I find a doctor with experience treating HA20?
When should someone with HA20 seek urgent eye evaluation?
Get notified when new evidence is published on A20 haploinsufficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
How I Treat: Haploinsufficiency of A20.
Li J, Zhou JY, Carpio Tumba M, et al.
Journal of human immunity 2026; (2(4)):e20250138 doi:10.70962/jhi.20250138.
PMID: 42169681 - 2
The Complexity of Being A20: From Biological Functions to Genetic Associations.
Karri U, Harasimowicz M, Carpio Tumba M, Schwartz DM
Journal of clinical immunology 2024; (44(3)):76 doi:10.1007/s10875-024-01681-1.
PMID: 38451381 - 3
The Added Value of a Multidisciplinary Clinic for Systemic Autoinflammatory Diseases.
Zinterl C, Costa-Reis P, Esteves IC, et al.
Journal of multidisciplinary healthcare 2022; (15()):999-1010 doi:10.2147/JMDH.S351546.
PMID: 35548670 - 4
Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.
Di Donato G, d'Angelo DM, Breda L, Chiarelli F
International journal of molecular sciences 2021; (22(12)) doi:10.3390/ijms22126360.
PMID: 34198614 - 5
Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution.
He T, Wang J, Carpio Tumba M, et al.
The Journal of allergy and clinical immunology 2026; (157(6)):1395-1410 doi:10.1016/j.jaci.2026.02.002.
PMID: 41692116 - 6
Tackling the diagnosis of HA20 in children: challenges of a highly variable clinical and genetic spectrum.
Anselmi F, Frémond ML, Remaux H, et al.
RMD open 2026; (12(1)) doi:10.1136/rmdopen-2025-006379.
PMID: 41741169 - 7
Ocular involvement in monogenic autoinflammatory disease.
Maccora I, Marrani E, Mastrolia MV, et al.
Autoimmunity reviews 2021; (20(11)):102944 doi:10.1016/j.autrev.2021.102944.
PMID: 34509650 - 8
Case Report: A novel mutation in TNFAIP3 in a patient with type 1 diabetes mellitus and haploinsufficiency of A20.
Cao C, Fu X, Wang X
Frontiers in endocrinology 2023; (14()):1131437 doi:10.3389/fendo.2023.1131437.
PMID: 37324276 - 9
Five children with haploinsufficiency of A20 caused by heterozygous mutations in the TNFAIP3 gene.
Yao H, Liu Y, Dong M, et al.
Frontiers in immunology 2026; (17()):1738656 doi:10.3389/fimmu.2026.1738656.
PMID: 41890736 - 10
A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.
Aeschlimann FA, Batu ED, Canna SW, et al.
Annals of the rheumatic diseases 2018; (77(5)):728-735 doi:10.1136/annrheumdis-2017-212403.
PMID: 29317407 - 11
[A report of clinical characteristics of 2 Chinese pedigrees with haploinsufficiency of A20 and literature review].
Zhong LQ, Wang W, Wang L, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2019; (57(12)):922-927 doi:10.3760/cma.j.issn.0578-1310.2019.12.006.
PMID: 31795558 - 12
The First Case of an Infant with Familial A20 Haploinsufficiency in Korea.
Kim HY, Song JY, Kim WI, et al.
Journal of Korean medical science 2020; (35(30)):e252 doi:10.3346/jkms.2020.35.e252.
PMID: 32743991 - 13
Clinical features and genetic analysis of A20 haploinsufficiency.
Xue F, An C, Lei Z, et al.
Orphanet journal of rare diseases 2025; (20(1)):457 doi:10.1186/s13023-025-04004-8.
PMID: 40859316 - 14
Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood.
Welzel T, Benseler SM, Kuemmerle-Deschner JB
Frontiers in immunology 2021; (12()):516427 doi:10.3389/fimmu.2021.516427.
PMID: 33868220 - 15
Empiric treatment for persistent fever from suspected autoinflammatory disease: Experience from an undiagnosed diseases program.
Shen JZ, Callaway K, Korf B, et al.
The American journal of the medical sciences 2023; (366(1)):71-75 doi:10.1016/j.amjms.2023.04.008.
PMID: 37062430
This page is for informational purposes only and does not constitute medical advice or replace guidance from your HA20 care team. Your clinicians should tailor referrals, testing, monitoring, and emergency plans to your or your child's situation.